Skip to main content

Use of Iron Therapy for Pediatric Patients

CBE ID
1433
Endorsed
Endorsement Status
1.1 New or Maintenance
E&M Cycle
Is Under Review
No
1.3 Measure Description

Percentage of all pediatric (less than 18 years old) in-center hemodialysis, home hemodialysis, and peritoneal dialysis patients with hemoglobin less than 11.0 g/dL and in whom serum ferritin concentration was less than 100 ng/ml and TSAT less than 20% who received IV iron or were prescribed oral iron within the following three months.

        • 1.14 Numerator

          Number of patients in the denominator who received IV iron or were prescribed oral iron within three months following the first occurrence of serum ferritin <100 ng/mL and transferrin saturation (TSAT) <20% during the study period.

        • 1.15 Denominator

          All pediatric (less than 18 years old) in-center hemodialysis, home hemodialysis, and peritoneal dialysis patients with hemoglobin less than 11 g/dL and in whom serum ferritin was less than 100 ng/mL and TSATless than 20% during the three month study period.

        • Exclusions

          None.

        • Most Recent Endorsement Activity
          Measure Retired and Endorsement Removed National Voluntary Consensus Standards for End Stage Renal Disease
          Initial Endorsement
          Last Updated
          Removal Date